Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jan 25, 2023 12:47pm
148 Views
Post# 35245530

RE:RE:RE:RE:RE:RE:RE:RE:Great ... I think...

RE:RE:RE:RE:RE:RE:RE:RE:Great ... I think...You'd be rosey too if you managed to pick up some shares in the low thirties..and we are working our way steadily back to the pre-FatFinger levels.

Just disappointed I wasn't able to pick up more than I did.  Hopefully there will be another chance.  Good either way.

I think that actually I have been quite prescient ... although my underlying valuation estimates have yet to be proven out...I'm confident that eventually they will be in due time.

Occassionally my timing has been off due to the pandemic, strategic delays, or Mgt. error...but it's so hard to tell with Seto and his over promising and underdelivery (excused, thusfar by the BOD)

Did you not get the memo that Spectral's cash outflow w.r.t. Dialco has been reduced substantially - implying that Infomed will pick up the majority of the expenses from here (btw there is more to do than just run a 30 person study)

MM
<< Previous
Bullboard Posts
Next >>